Your browser doesn't support javascript.
loading
Germline genetic contribution to the immune landscape of cancer.
Sayaman, Rosalyn W; Saad, Mohamad; Thorsson, Vésteinn; Hu, Donglei; Hendrickx, Wouter; Roelands, Jessica; Porta-Pardo, Eduard; Mokrab, Younes; Farshidfar, Farshad; Kirchhoff, Tomas; Sweis, Randy F; Bathe, Oliver F; Heimann, Carolina; Campbell, Michael J; Stretch, Cynthia; Huntsman, Scott; Graff, Rebecca E; Syed, Najeeb; Radvanyi, Laszlo; Shelley, Simon; Wolf, Denise; Marincola, Francesco M; Ceccarelli, Michele; Galon, Jérôme; Ziv, Elad; Bedognetti, Davide.
Affiliation
  • Sayaman RW; Department of Population Sciences, Beckman Research Institute, City of Hope Comprehensive Cancer Center, Duarte, CA 91010, USA; Department of Laboratory Medicine, Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, CA 94143, USA; Biological Scienc
  • Saad M; Qatar Computing Research Institute, Hamad Bin Khalifa University, Doha, Qatar; Neuroscience Research Center, Faculty of Medical Sciences, Lebanese University, Beirut, Lebanon.
  • Thorsson V; Institute for Systems Biology, Seattle, WA 98109, USA.
  • Hu D; Department of Medicine, Institute for Human Genetics, Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, CA 94143, USA.
  • Hendrickx W; Research Branch, Sidra Medicine, PO Box 26999 Doha, Qatar; College of Health and Life Sciences, Hamad Bin Khalifa University, Doha, Qatar.
  • Roelands J; Research Branch, Sidra Medicine, PO Box 26999 Doha, Qatar; Department of Surgery, Leiden University Medical Center, 2333 ZA Leiden, the Netherlands.
  • Porta-Pardo E; Barcelona Supercomputing Center (BSC); Josep Carreras Leukaemia Research Institute (IJC), Badalona, 08034 Barcelona, Catalonia, Spain.
  • Mokrab Y; Research Branch, Sidra Medicine, PO Box 26999 Doha, Qatar; College of Health and Life Sciences, Hamad Bin Khalifa University, Doha, Qatar; Weill Cornell Medicine, Doha, Qatar.
  • Farshidfar F; Department of Oncology, University of Calgary, Alberta AB T2N 4N1, Canada; Arnie Charbonneau Cancer Institute, Calgary, Alberta AB T2N 4N1, Canada; Department of Biomedical Data Science and Institute for Stem Cell Biology and Regenerative Medicine, School of Medicine, Stanford University, Stanford,
  • Kirchhoff T; Perlmutter Cancer Center, New York University School of Medicine, New York University Langone Health, New York, NY 10016, USA.
  • Sweis RF; Department of Medicine, Section of Hematology/Oncology, Committee on Clinical Pharmacology and Pharmacogenomics, Committee on Immunology, University of Chicago, Chicago, IL 60637, USA.
  • Bathe OF; Department of Oncology, University of Calgary, Alberta AB T2N 4N1, Canada; Arnie Charbonneau Cancer Institute, Calgary, Alberta AB T2N 4N1, Canada; Department of Surgery, University of Calgary, Calgary, Alberta AB T2N 4N1, Canada.
  • Heimann C; Institute for Systems Biology, Seattle, WA 98109, USA.
  • Campbell MJ; Department of Surgery, University of California, San Francisco, San Francisco, CA 94143, USA.
  • Stretch C; Department of Oncology, University of Calgary, Alberta AB T2N 4N1, Canada; Arnie Charbonneau Cancer Institute, Calgary, Alberta AB T2N 4N1, Canada.
  • Huntsman S; Department of Medicine, Institute for Human Genetics, Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, CA 94143, USA.
  • Graff RE; Department of Epidemiology and Biostatistics, University of California, San Francisco, San Francisco, CA 94143, USA.
  • Syed N; Research Branch, Sidra Medicine, PO Box 26999 Doha, Qatar; Department of Science and Technology, University of Sannio, 82100 Benevento, Italy.
  • Radvanyi L; Ontario Institute for Cancer Research, Toronto, Ontario M5G 0A3, Canada.
  • Shelley S; Department of Research and Development, Leukemia Therapeutics, LLC, Hull, MA 02045, USA.
  • Wolf D; Department of Laboratory Medicine, Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, CA 94143, USA.
  • Marincola FM; Refuge Biotechnologies Inc., Menlo Park, CA 94025, USA.
  • Ceccarelli M; Department of Electrical Engineering and Information Technology, University of Naples "Federico II," 80128 Naples, Italy; Istituto di Ricerche Genetiche "G. Salvatore," Biogem s.c.ar.l., 83031 Ariano Irpino, Italy.
  • Galon J; INSERM, Laboratory of Integrative Cancer Immunology, Equipe Labellisée Ligue Contre Le Cancer, Centre de Recherche de Cordeliers, Université de Paris, Sorbonne Université, Paris, France.
  • Ziv E; Department of Medicine, Institute for Human Genetics, Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, CA 94143, USA. Electronic address: elad.ziv@ucsf.edu.
  • Bedognetti D; Research Branch, Sidra Medicine, PO Box 26999 Doha, Qatar; College of Health and Life Sciences, Hamad Bin Khalifa University, Doha, Qatar; Department of Internal Medicine and Medical Specialties (Di.M.I.), University of Genoa, 16132 Genoa, Italy. Electronic address: dbedognetti@sidra.org.
Immunity ; 54(2): 367-386.e8, 2021 02 09.
Article in En | MEDLINE | ID: mdl-33567262
Subject(s)
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Killer Cells, Natural / T-Lymphocytes / Lymphocytes, Tumor-Infiltrating / Germ-Line Mutation / Immunotherapy / Neoplasms Type of study: Prognostic_studies Limits: Female / Humans / Male / Middle aged Language: En Journal: Immunity Journal subject: ALERGIA E IMUNOLOGIA Year: 2021 Type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Killer Cells, Natural / T-Lymphocytes / Lymphocytes, Tumor-Infiltrating / Germ-Line Mutation / Immunotherapy / Neoplasms Type of study: Prognostic_studies Limits: Female / Humans / Male / Middle aged Language: En Journal: Immunity Journal subject: ALERGIA E IMUNOLOGIA Year: 2021 Type: Article